RedShiftBio AQS3pro for protein secondary structure and drug development

Monday, 01 November, 2021 | Supplied by: ATA Scientific Pty Ltd

RedShiftBio AQS3pro for protein secondary structure and drug development

When developing biotherapeutics, the ability to measure and characterise changes in the secondary structure of proteins is critical. Proteins in solution are prone to conformational change or instability as structural bonds are disrupted by thermal and chemical stresses in the local environment. Any structural change has the potential to compromise efficacy and trigger aggregation which can impact safety, and therefore must be understood and controlled.

Conventional techniques such as FTIR and circular dichroism do not possess the adequate feature set for researchers to accurately assess changes in their proteins within the required conditions. The need for high sensitivity, a wide dynamic range, a simplified and automated workflow, and high repeatability is therefore significant.

The AQS3pro provides label-free protein analysis with a novel IR technique called microfluidic modulation spectroscopy (MMS). The technique is purposely designed to directly address the limitations of current technologies and provide drift-free, background-subtracted, high-sensitivity measurements of the protein secondary structure. It is possible to measure protein similarity (fingerprinting), quantitation, higher order structure, protein stability and aggregation through thermal and chemical denaturation methods using a walkaway automated platform.

The product allows users to ‘see change’ in the secondary structure of proteins across a wide concentration range from 0.1 to over 200 mg/mL, and in the presence of excipients — the concentration range found across the full spectrum of drug development. Samples can be measured with minimal preparation and without dilution to generate data that is reliably representative of drug performance.

The AQS3pro measures five key measurements — aggregation, quantitation, stability, similarity and structure — to directly support protein characterisation throughout the biopharmaceutical development pipeline.

For more information: https://www.atascientific.com.au/products/redshiftbio-aqs3pro/.

Online: www.atascientific.com.au
Phone: 02 9541 3500
Related Products

Jenoptik GRYPHAX Rigel monochrome microscope camera

The Jenoptik GRYPHAX Rigel is a monochrome microscope camera engineered for fluorescence...

Azure Biosystems Azure 400 Chemiluminescent Western Blot Imager

The Azure 400 by Azure Biosystems is a multichannel imaging system designed for...

Charm EZ Protect+ System Antibiotic Residue Testing

The Charm EZ Protect+ System is designed to bring rapid, reliable antibiotic residue testing to...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd